Back

argenx SE

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 03 dec 2018 - 07:16
  • Statutory name argenx SE
  • Title argenx enters exclusive global collaboration and license agreement with Cilag GmbH International, an affiliate of Janssen, for cusatuzumab (ARGX-110)

Related downloads

201812030000000002_argenx_2.pdf

Date last update: 20 January 2019

Share information

Share on: Share this